Fatima Valdes-Mora

12PUBLICATIONS
120CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 11, 2026
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling.

|Jan 14, 2026
Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma.

Holly Holliday, Aaminah Khan, Anahid Ehteda

|Aug 14, 2025
Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and Implications.

Dana Kisswani, Christina Carroll, Fatima Valdes-Mora

|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt

|May 05, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt

|Feb 24, 2023
Pleiotrophin drives a prometastatic immune niche in breast cancer.

Debolina Ganguly, Marcel O Schmidt, Morgan Coleman

Pageof 2

Frequent Collaborators

5 joint publications

David Gallego-Ortega

2 joint publications

Paul Timpson

2 joint publications

Evangeline R Jackson

2 joint publications

Alexander Swarbrick